Pawel Rogala

Cracow Branch
Krakow, MA 31115, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Current Treatment Standards for Metastatic Uveal Melanoma.

Current Treatment Standards for Metastatic Uveal Melanoma.

Journal: Cancers

Published: December 03, 2025

Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma.

Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma.

Journal: Clinical and translational radiation oncology

Published: May 28, 2025

Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.

Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 09, 2025

Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor.

Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 06, 2025

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin.

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin.

Journal: Scientific reports

Published: August 29, 2024

Long-term outcomes of sequential chemotherapy in epithelioid sarcoma.

Long-term outcomes of sequential chemotherapy in epithelioid sarcoma.

Journal: Journal of chemotherapy (Florence, Italy)

Published: August 08, 2024

Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy.

Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy.

Journal: Journal of chemotherapy (Florence, Italy)

Published: July 08, 2024

Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.

Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.

Journal: Cancer

Published: November 23, 2023

Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.

Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 19, 2023

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.

Journal: Cancers

Published: July 05, 2023

What impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead?

What impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead?

Journal: Expert opinion on pharmacotherapy

Published: May 05, 2023

Myocarditis Induced by Immunotherapy in Metastatic Melanoma-Review of Literature and Current Guidelines.

Myocarditis Induced by Immunotherapy in Metastatic Melanoma-Review of Literature and Current Guidelines.

Journal: Journal of clinical medicine

Published: June 25, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026